Weiss Asset Management secured a board seat in Theravance Biopharma, Inc
Key Summary: On April 12, 2023, James C. Kelly, a managing director of Weiss Asset Management, was appointed to the Board
Market Cap: $728 million| Theravance Biopharma, Inc is a biopharmaceutical company primarily focused on the discovery, development, and commercialization of medicines.
On April 12, 2023, at the invitation of the company, James C. Kelly, a managing director of Weiss Asset Management, was appointed to the Board. Source
Member discussion